Modern treatments and future directions for newly diagnosed multiple myeloma patients

Best Practice & Research. Clinical Haematology
Sydney X Lu

Abstract

Over the course of the past decade-plus, the therapy of newly diagnosed multiple myeloma has seen incredible advances in the domains of diagnostic evaluation, active medical therapy, and response evaluation. This manuscript reviews the evaluation and management of newly diagnosed active multiple myeloma, with a focus on major clinical trials and IMWG recommendations. The paper describes a current approach for the initial evaluation and workup for patients with putative active myeloma, with consideration towards potential MRD-directed therapeutic approaches and future clinical trials, and then discusses management with a focus on induction regimens with attention primarily to modern three and four-drug combinations for transplant-eligible and transplant-ineligible patients, and those with organ dysfunction. Finally, this article briefly reviews minimal residual disease directed therapy approaches, primarily in the context of whether eligible patients should be referred for high dose chemotherapy and autologous stem cell rescue. Maintenance therapy for both transplant eligible and ineligible patients is discussed elsewhere in this issue.

References

Jul 21, 2006·Leukemia·B G M DurieUNKNOWN International Myeloma Working Group
Feb 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jens HillengassHartmut Goldschmidt
Feb 5, 2011·Blood·S Vincent RajkumarUNKNOWN International Myeloma Workshop Consensus Panel 1
Aug 5, 2011·The New England Journal of Medicine·S Vincent RajkumarRobert A Kyle
May 22, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evangelos TerposG David Roodman
Sep 4, 2014·The New England Journal of Medicine·Lotfi BenboubkerUNKNOWN FIRST Trial Team
Dec 3, 2014·The Lancet Oncology·S Vincent RajkumarJesus F San Miguel
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosEvangelos Terpos
Jan 28, 2015·Nature Reviews. Clinical Oncology·Sham MailankodyOla Landgren
Aug 5, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PalumboPhilippe Moreau
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosEvangelos Terpos
Feb 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raphael SzalatNikhil C Munshi
Apr 6, 2017·The New England Journal of Medicine·Michel AttalUNKNOWN IFM 2009 Study
Sep 13, 2017·Mediterranean Journal of Hematology and Infectious Diseases·Alessandro Corso, Silvia Mangiacavalli
Dec 13, 2017·The New England Journal of Medicine·María-Victoria MateosUNKNOWN ALCYONE Trial Investigators
May 10, 2018·British Journal of Haematology·Elizabeth K O'DonnellNoopur S Raje
Feb 15, 2019·Blood·Evangelos TerposMeletios A Dimopoulos
Mar 29, 2019·Science Translational Medicine·Eric L SmithRenier J Brentjens
May 3, 2019·The New England Journal of Medicine·Noopur RajeJames N Kochenderfer
May 30, 2019·The New England Journal of Medicine·Thierry FaconUNKNOWN MAIA Trial Investigators
Jun 11, 2019·Expert Review of Molecular Diagnostics·Anna Monter, Josep F Nomdedéu

❮ Previous
Next ❯

Citations

Mar 13, 2021·Future Oncology·Joshua RichterMeletios Dimopoulos
May 29, 2021·Frontiers in Pharmacology·Lívia Pena SilveiraAdriano Max Moreira Reis
Aug 4, 2021·Future Oncology·José-Ángel Hernández-RivasErnesto Pérez Persona

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Chiaki Nakaseko
International Journal of Hematologic Oncology
Jagoda K Jasielec, Andrzej J Jakubowiak
Current Hematologic Malignancy Reports
Karie D Runcie, Tomer M Mark
© 2021 Meta ULC. All rights reserved